Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Using a Novel Bi-directional Device
Public ClinicalTrials.gov record NCT01624662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 16-Week Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (Bid) Using a Novel Bi-directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-week, Open-label Extension Phase to Assess Safety
Study identification
- NCT ID
- NCT01624662
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Optinose US Inc.
- Industry
- Enrollment
- 323 participants
Conditions and interventions
Conditions
Interventions
- Fluticasone propionate Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 29, 2013
- Primary completion
- May 10, 2015
- Completion
- Jul 2, 2015
- Last update posted
- Dec 4, 2018
2013 – 2015
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bensch Clinical Research LLC | Stockton | California | 95207 | — |
| Colorado Allergy & Asthma Centers, PC | Centennial | Colorado | 80112 | — |
| Advanced ENT and Allergy | Louisville | Kentucky | 40207 | — |
| Institute for Asthma and Allergy | Wheaton | Maryland | 20902 | — |
| Atlantic Research Center, LLC | Ocean City | New Jersey | 07712 | — |
| Allergy and Asthma Research Group | Eugene | Oregon | 97401 | — |
| Baker Allergy, Asthma and Dermatology Research Center, LLC | Lake Oswego | Oregon | 98225 | — |
| Valley Clinical Research Center | Bethlehem | Pennsylvania | 18020 | — |
| University of Vermont | Burlington | Vermont | 05405 | — |
| Bellingham Asthma, Allergy, and Immunology Clinic | Bellingham | Washington | 98225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01624662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 4, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01624662 live on ClinicalTrials.gov.